He Cured His Own Disease; Reader’s Digest, May 2020

[embedyt] https://www.youtube.com/watch?v=xeA1rbkhtZE[/embedyt]

[embedyt] https://www.youtube.com/watch?v=0HFHfTd9-Y8[/embedyt] Check out the above video about our COVID19 drug repurposing work or go to: https://youtu.be/0HFHfTd9-Y8 Thank you to Jimmy Baggott for making this amazing video! #ThinkItDoIt #FromHopeToAction #ChasingMyCure #ChasingCOVIDsCure   David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist, disease hunter, speaker, and bestselling author of the acclaimed memoir, Chasing My Cure: A…

As I’ve shared before, repurposing existing drugs to treat COVID19 (and every other disease) is our best opportunity to save lives as quickly as possible. One drug that is being repurposed and has gotten a lot of attention is tocilizumab (Actemra). As I shared in #ChasingMyCure (excerpt below), it was originally developed by my friend…

We Announced the $48.3M Federal Partnership at the White House! It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me. While on stage, I couldn’t help but think back to 14 years ago when I…

I’m so proud of my team at the University of Pennsylvania’s Center for Study & Treatment of Lymphadenopathies & Cytokine Storms. Today, five years worth of research into mechanisms involved in the idiopathic multicentric Castleman disease (iMCD) cytokine storm, which has major implications for other cytokine storms like COVID19, were published in two high-impact journals….

Wow, my head is spinning from these recent clinical trial results. Within minutes of one another, two conflicting studies were released. The first I’ll highlight is of tocilizumab (the drug that my friend and colleague Kazu Yoshizaki developed to treat Castleman disease and tested on himself to prove that it was safe before giving it…